Sanofi’s Toronto Investment Expands Canada’s Vaccine Manufacturing Capacity

Ontario Celebrates Grand Opening Of Sanofi’s Newest Biomanufacturing Facility

ONTARIO-The Ontario government joined Sanofi, a global biopharmaceutical company, to announce the official inauguration of their new $925 million vaccine manufacturing facility at the Connaught Campus in North York. At 263,000 square feet, the Charles Best building stands as the largest manufacturing mandate of its kind for Sanofi’s Canadian operations and will serve as the […]

Sanofi inaugurates Toronto facility that will produce seasonal flu vaccines for Canadians

French pharmaceutical maker’s site is also designed to provide new capacity for vaccine production in event of another pandemic

Sanofi’s Toronto investment expands Canada’s vaccine manufacturing capacity

The North York site is now the central hub for manufacturing, formulation, filling and packaging of Sanofi’s Fluzone high-dose influenza vaccine for adults 65 years and older.

Sanofi opens $925-million flu vaccine facility in Toronto

Sanofi has officially opened a massive new flu‑vaccine manufacturing facility in Toronto — a $925‑million project billed as the largest single bio-manufacturing investment in Canadian history. The Charles Best Building, located on Sanofi’s 52‑acre Toronto campus, will produce Fluzone High‑Dose, a high‑potency influenza vaccine designed for adults 65 and older, who account for the majority […]

Ontario - Ontario Celebrates Grand Opening of Sanofi's Newest Biomanufacturing Facility

On September 16, the Ontario government joined Sanofi, a global biopharmaceutical company, to celebrate the official inauguration of their new $925 million vaccine manufacturing facility at the hist. . .

Sanofi inaugurates $661 million vaccine facility in Toronto

The expansion marks the single-largest biomanufacturing facility investment in Canadian history.